plerixafor has been researched along with Amyloidosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrea, N; Lee, SY; Mark Sloan, J; Quillen, K; Sanchorawala, V; Seldin, DC | 1 |
| Chaulagain, C; Comenzo, RL; Kaul, E; Shah, G | 1 |
| Arce-Lara, C; D'Souza, A; Dhakal, B; Drobyski, W; Eastwood, D; Esselman, J; Hamadani, M; Hari, PN; Pasquini, M; Rizzo, JD; Saber, W; Strouse, C | 1 |
| Arce-Lara, C; D'Souza, A; Dhakal, B; Esselman, J; Falvo, F; Fenske, T; Hamadani, M; Hari, PN; Pasquini, M; Saber, W; Zellner, K | 1 |
| Adami, F; Branca, A; Colpo, A; Lessi, F; Marino, F; Marson, P; Tison, T | 1 |
| Adami, F; Fedrigo, M; Galli, M; Lessi, F; Rambaldi, A; Rosa, GD | 1 |
| Dunn, D; Jagasia, M; Savani, BN; Vikas, P | 1 |
1 review(s) available for plerixafor and Amyloidosis
| Article | Year |
|---|---|
Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease.
Topics: Amyloid; Amyloidosis; Anti-HIV Agents; Benzylamines; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Immunoglobulin Light Chains; Kidney Failure, Chronic; Lymphocytes; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation, Autologous | 2012 |
1 trial(s) available for plerixafor and Amyloidosis
| Article | Year |
|---|---|
Plerixafor and abbreviated-course granulocyte colony-stimulating factor for mobilizing hematopoietic progenitor cells in light chain amyloidosis.
Topics: Adult; Aged; Amyloidosis; Anti-HIV Agents; Autografts; Benzylamines; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Middle Aged | 2014 |
5 other study(ies) available for plerixafor and Amyloidosis
| Article | Year |
|---|---|
Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series.
Topics: Amyloidosis; Antineoplastic Agents, Alkylating; Benzylamines; Cyclams; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Heart Failure; Heart Transplantation; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Melphalan; Middle Aged; Remission Induction; Transplantation, Autologous | 2014 |
Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis.
Topics: Aged; Amyloidosis; Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Immunoglobulin Light-chain Amyloidosis; Middle Aged | 2014 |
Superior efficacy but higher cost of plerixafor and abbreviated-course G-CSF for mobilizing hematopoietic progenitor cells (HPC) in AL amyloidosis.
Topics: Amyloidosis; Benzylamines; Costs and Cost Analysis; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Male; Retrospective Studies | 2015 |
Spontaneous splenic rupture following stem cell mobilization with G-CSF and plerixafor in AL amyloidosis.
Topics: Adult; Amyloidosis; Benzylamines; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Rupture, Spontaneous; Splenic Rupture | 2016 |
Mobilization of peripheral blood hematopoietic stem cells by granulocyte-colony stimulating factor and plerixafor in patients with cardiac AL amyloidosis.
Topics: Amyloidosis; Benzylamines; Cyclams; Female; Granulocyte Colony-Stimulating Factor; Heart Diseases; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Immunoglobulin Light Chains; Male; Middle Aged | 2015 |